Andra E Batlin, MD
Internal Medicine · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 25 years
- Graduated 2001
Offices
1 location · Lakowsky and Batlin Medical Corp. · 2 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Batlin’s office at (650) 552-8180 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A87310 · Current
Licensed to practise in California · since 2004 · expires 2027-12-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$57,269
Medicare paid this office $57,269 for 166 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 153 | $25,272 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 130 | $20,297 | $156 |
| Advance care planning, first 30 minutes | 137 | $9,781 | $71 |
Who their Medicare patients are
166 Original Medicare patients in 2024. Average age 76 · Women 92% · Health risk score 0.96. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 58% · Cancer 23% · Coronary heart disease 17% · Depression 16% · Chronic kidney disease 13% · Atrial fibrillation 13% · Diabetes 11% · Heart failure 7%.
The office billed $102,078, Medicare allowed $67,986 and paid $57,269; for 515 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 166 | 515 | 76 | 0.96 | $102,078 | $57,269 |
| 2023 | 210 | 902 | 75 | 1.00 | $178,434 | $95,926 |
| 2022 | 202 | 647 | 75 | 0.94 | $100,119 | $64,682 |
| 2021 | 192 | 612 | 75 | 1.02 | $90,107 | $62,532 |
| 2020 | 188 | 644 | 74 | 1.05 | $96,649 | $52,053 |
| 2019 | 169 | 709 | 74 | 1.00 | $98,635 | $59,867 |
| 2018 | 162 | 633 | 75 | 1.02 | $87,379 | $53,527 |
| 2017 | 133 | 553 | 74 | 1.06 | $74,644 | $46,990 |
| 2016 | 129 | 431 | 74 | 1.04 | $66,741 | $35,475 |
| 2015 | 134 | 590 | 74 | 1.02 | $82,901 | $51,172 |
| 2014 | 110 | 374 | 74 | 0.77 | $50,994 | $26,225 |
| 2013 | 87 | 288 | 75 | 0.78 | $41,905 | $21,827 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 202 | $49,161 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 179 | $28,015 | $157 |
| Advance care planning, first 30 minutes | 188 | $12,814 | $68 |
| Administration of influenza virus vaccine | 19 | $640 | $32 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 20 | $459 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $199 | $14 |
2022: 7 services
| Return visit (30+ min) | 156 | $24,299 | $105 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 145 | $22,659 | $156 |
| Advance care planning, first 30 minutes | 158 | $9,946 | $63 |
| Short return visit (20+ min) | 18 | $1,355 | $68 |
| Administration of influenza virus vaccine | 24 | $727 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 24 | $504 | $21 |
| Administration of pneumococcal vaccine | 11 | $332 | $30 |
2021: 6 services
| Return visit (30+ min) | 127 | $21,590 | $115 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 133 | $21,130 | $159 |
| Advance care planning, first 30 minutes | 147 | $8,992 | $61 |
| Short return visit (20+ min) | 64 | $5,762 | $78 |
| Administration of influenza virus vaccine | 21 | $445 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 21 | $431 | $21 |
2020: 4 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 128 | $18,007 | $141 |
| Return visit (30+ min) | 112 | $14,830 | $78 |
| Advance care planning, first 30 minutes | 138 | $8,185 | $59 |
| Short return visit (20+ min) | 91 | $6,683 | $47 |
2019: 10 services
| Return visit (30+ min) | 139 | $20,487 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 130 | $18,009 | $139 |
| Advance care planning, first 30 minutes | 135 | $8,580 | $63 |
| Pneumococcal vaccine, 23-valent | 27 | $2,978 | $110 |
| Pneumococcal vaccine, 13-valent | 12 | $2,512 | $209 |
| Short return visit (20+ min) | 23 | $1,350 | $54 |
| Administration of influenza virus vaccine | 38 | $787 | $20 |
| Administration of pneumococcal vaccine | 39 | $787 | $20 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 38 | $727 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $181 | $15 |
2018: 10 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 121 | $16,736 | $138 |
| Return visit (30+ min) | 112 | $15,324 | $90 |
| Advance care planning, first 30 minutes | 129 | $8,691 | $67 |
| Short return visit (20+ min) | 42 | $2,792 | $55 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 12 | $2,333 | $194 |
| Pneumococcal vaccine, 23-valent | 16 | $1,689 | $106 |
| Administration of influenza virus vaccine | 37 | $986 | $25 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 32 | $597 | $19 |
| Administration of pneumococcal vaccine | 20 | $506 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $227 | $15 |
2017: 9 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 96 | $13,248 | $138 |
| Return visit (30+ min) | 72 | $9,870 | $97 |
| Short return visit (20+ min) | 70 | $6,939 | $64 |
| Advance care planning, first 30 minutes | 100 | $6,426 | $64 |
| Pneumococcal vaccine, 23-valent | 26 | $2,431 | $94 |
| Pneumococcal vaccine, 13-valent | 11 | $2,054 | $187 |
| Administration of pneumococcal vaccine | 37 | $1,088 | $29 |
| Administration of influenza virus vaccine | 20 | $588 | $29 |
| Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 15 | $283 | $19 |
2016: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 90 | $11,617 | $129 |
| Return visit (30+ min) | 64 | $7,345 | $77 |
| Short return visit (20+ min) | 64 | $4,889 | $58 |
| Pneumococcal vaccine, 13-valent | 21 | $3,641 | $173 |
| Advance care planning, first 30 minutes | 21 | $1,513 | $72 |
| Administration of influenza virus vaccine | 26 | $794 | $29 |
| Administration of pneumococcal vaccine | 24 | $706 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 25 | $409 | $16 |
2015: 10 services
| Pneumococcal vaccine, 13-valent | 73 | $12,256 | $168 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 54 | $10,276 | $190 |
| Return visit (30+ min) | 71 | $10,016 | $89 |
| Short return visit (20+ min) | 70 | $4,706 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 35 | $4,558 | $130 |
| Administration of pneumococcal vaccine | 75 | $2,205 | $29 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $1,998 | $182 |
| Administration of influenza virus vaccine | 49 | $1,529 | $29 |
| Long return visit (40+ min) | 11 | $1,298 | $108 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 48 | $790 | $15 |
2014: 6 services
| Return visit (30+ min) | 61 | $8,695 | $80 |
| Short return visit (20+ min) | 65 | $6,672 | $60 |
| Long return visit (40+ min) | 39 | $3,851 | $99 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,350 | $129 |
| Administration of influenza virus vaccine | 28 | $823 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 26 | $392 | $15 |
2013: 6 services
| Return visit (30+ min) | 56 | $9,710 | $83 |
| Long return visit (40+ min) | 47 | $6,109 | $120 |
| Short return visit (20+ min) | 21 | $1,690 | $50 |
| New patient visit (45+ min) | 13 | $1,528 | $118 |
| Administration of influenza virus vaccine | 20 | $619 | $29 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 12 | $154 | $12 |
Drugs they prescribed that Part D paid
$77,643
Pharmacies billed $77,643 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,286) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,137 generic and 149 brand-name prescriptions · $77,643 in drug cost · 15 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 16 | $15,367 | $960 |
| Levothyroxine | 120 | $2,324 | $19 |
| Atorvastatin | 162 | $1,570 | $10 |
| Synthroid | 16 | $993 | $62 |
| Escitalopram | 54 | $828 | $15 |
See all 30 drugs
| Ozempic | 16 | $15,367 | $960 |
| Levothyroxine | 120 | $2,324 | $19 |
| Atorvastatin | 162 | $1,570 | $10 |
| Synthroid | 16 | $993 | $62 |
| Escitalopram | 54 | $828 | $15 |
| Bisoprolol-Hydrochlorothiazide | 22 | $805 | $37 |
| Simvastatin | 56 | $790 | $14 |
| Famotidine | 21 | $750 | $36 |
| Ezetimibe | 14 | $487 | $35 |
| Omeprazole | 46 | $486 | $11 |
| Rosuvastatin | 50 | $465 | $9 |
| Albuterol Sulfate Hfa | 16 | $455 | $28 |
| Lisinopril | 55 | $426 | $8 |
| Metformin Hcl Er | 37 | $379 | $10 |
| Metoprolol | 25 | $374 | $15 |
| Acyclovir | 12 | $326 | $27 |
| Valsartan | 14 | $305 | $22 |
| Fluticasone Propionate | 14 | $290 | $21 |
| Amlodipine Besylate | 34 | $275 | $8 |
| Duloxetine | 14 | $268 | $19 |
| Bupropion Hcl Sr | 15 | $241 | $16 |
| Montelukast | 13 | $233 | $18 |
| Venlafaxine Hcl Er | 20 | $227 | $11 |
| Paroxetine | 14 | $223 | $16 |
| Losartan | 24 | $189 | $8 |
| Hydrochlorothiazide | 39 | $168 | $4 |
| Sumatriptan | 13 | $104 | $8 |
| Carvedilol | 12 | $98 | $8 |
| Alendronate | 13 | $67 | $5 |
| Spironolactone | 11 | $16 | $1 |
Year by year
| 2024 | 1,286 | 195 | 0% (0) | 12% | $77,643 |
| 2023 | 1,540 | 215 | 0% (0) | None | $93,307 |
| 2022 | 1,486 | 198 | 0% (0) | None | $62,335 |
| 2021 | 1,369 | 185 | 0% (0) | None | $72,591 |
| 2020 | 1,360 | 176 | 0% (0) | None | $67,964 |
| 2019 | 1,303 | 179 | 0% (0) | None | $73,262 |
| 2018 | 1,607 | 184 | 1% (17) | None | $98,807 |
| 2017 | 1,454 | 166 | 2% (25) | None | $80,705 |
| 2016 | 1,588 | 171 | 1% (16) | None | $82,218 |
| 2015 | 1,699 | 154 | None | None | $84,711 |
| 2014 | 1,426 | 150 | 2% (21) | None | $71,456 |
| 2013 | 1,408 | 134 | 1% (15) | None | $63,338 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Ozempic | 16 | $15,279 | $955 |
| Rybelsus | 12 | $12,132 | $1,011 |
| Levothyroxine | 158 | $3,091 | $20 |
| Acyclovir | 12 | $2,921 | $243 |
| Atorvastatin | 166 | $2,121 | $13 |
| Synthroid | 13 | $1,543 | $119 |
| Bisoprolol-Hydrochlorothiazide | 21 | $1,368 | $65 |
| Valsartan-Hydrochlorothiazide | 15 | $1,096 | $73 |
| Escitalopram | 50 | $975 | $19 |
| Losartan | 24 | $754 | $31 |
| Simvastatin | 76 | $721 | $9 |
| Alendronate | 40 | $681 | $17 |
| Esomeprazole Magnesium | 11 | $673 | $61 |
| Fluticasone Propionate | 27 | $666 | $25 |
| Metformin Hcl Er | 41 | $657 | $16 |
| Famotidine | 25 | $643 | $26 |
| Albuterol Sulfate Hfa | 18 | $626 | $35 |
| Rosuvastatin | 34 | $558 | $16 |
| Lisinopril | 59 | $463 | $8 |
| Omeprazole | 44 | $442 | $10 |
| Ondansetron Odt | 13 | $434 | $33 |
| Metoprolol | 23 | $432 | $19 |
| Amlodipine Besylate | 39 | $352 | $9 |
| Montelukast | 22 | $314 | $14 |
| Bupropion Hcl Sr | 17 | $280 | $16 |
| Sumatriptan | 20 | $269 | $13 |
| Venlafaxine Hcl Er | 14 | $260 | $19 |
| Hydrochlorothiazide | 50 | $229 | $5 |
| Pravastatin | 16 | $216 | $14 |
| Paroxetine | 17 | $171 | $10 |
| Spironolactone | 19 | $161 | $8 |
| Celecoxib | 11 | $98 | $9 |
| Gabapentin | 12 | $75 | $6 |
2022: 35 drugs
| Eliquis | 13 | $9,597 | $738 |
| Janumet | 12 | $6,665 | $555 |
| Levothyroxine | 139 | $2,520 | $18 |
| Atorvastatin | 185 | $2,046 | $11 |
| Bisoprolol-Hydrochlorothiazide | 25 | $1,772 | $71 |
| Rosuvastatin | 24 | $1,553 | $65 |
| Synthroid | 12 | $1,243 | $104 |
| Duloxetine | 24 | $1,036 | $43 |
| Albuterol Sulfate Hfa | 16 | $888 | $55 |
| Escitalopram | 52 | $780 | $15 |
| Simvastatin | 76 | $765 | $10 |
| Latanoprost | 11 | $674 | $61 |
| Lisinopril | 67 | $646 | $10 |
| Alendronate | 43 | $487 | $11 |
| Amlodipine Besylate | 25 | $481 | $19 |
| Famotidine | 30 | $438 | $15 |
| Metformin Hcl Er | 53 | $428 | $8 |
| Omeprazole | 37 | $409 | $11 |
| Bupropion Hcl Sr | 21 | $402 | $19 |
| Esomeprazole Magnesium | 12 | $386 | $32 |
| Fluticasone Propionate | 15 | $380 | $25 |
| Metoprolol | 30 | $378 | $13 |
| Montelukast | 24 | $373 | $16 |
| Losartan | 36 | $366 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $296 | $19 |
| Venlafaxine Hcl Er | 22 | $288 | $13 |
| Gabapentin | 18 | $267 | $15 |
| Hydrochlorothiazide | 47 | $205 | $4 |
| Citalopram Hbr | 18 | $200 | $11 |
| Sertraline | 12 | $194 | $16 |
| Celecoxib | 11 | $166 | $15 |
| Paroxetine | 18 | $155 | $9 |
| Pravastatin | 11 | $123 | $11 |
| Meloxicam | 11 | $121 | $11 |
| Atenolol | 12 | $90 | $7 |
2021: 28 drugs
| Spiriva Respimat | 22 | $13,265 | $603 |
| Eliquis | 18 | $12,782 | $710 |
| Levothyroxine | 133 | $3,005 | $23 |
| Atorvastatin | 165 | $2,065 | $13 |
| Bisoprolol | 18 | $1,969 | $109 |
| Rosuvastatin | 26 | $1,563 | $60 |
| Bisoprolol-Hydrochlorothiazide | 23 | $1,309 | $57 |
| Duloxetine | 26 | $952 | $37 |
| Escitalopram | 52 | $943 | $18 |
| Simvastatin | 75 | $803 | $11 |
| Esomeprazole Magnesium | 18 | $675 | $37 |
| Lisinopril | 49 | $578 | $12 |
| Losartan | 35 | $553 | $16 |
| Omeprazole | 30 | $530 | $18 |
| Famotidine | 26 | $515 | $20 |
| Metoprolol | 16 | $411 | $26 |
| Amlodipine Besylate | 40 | $397 | $10 |
| Venlafaxine Hcl Er | 19 | $395 | $21 |
| Montelukast | 26 | $362 | $14 |
| Alendronate | 25 | $333 | $13 |
| Triamterene-Hydrochlorothiazid | 22 | $325 | $15 |
| Paroxetine | 11 | $279 | $25 |
| Metformin Hcl Er | 34 | $243 | $7 |
| Hydrochlorothiazide | 56 | $234 | $4 |
| Citalopram Hbr | 19 | $217 | $11 |
| Sertraline | 18 | $171 | $10 |
| Pravastatin | 11 | $149 | $14 |
| Gabapentin | 19 | $63 | $3 |
2020: 31 drugs
| Eliquis | 13 | $6,055 | $466 |
| Metformin Er Gastric | 12 | $4,665 | $389 |
| Levothyroxine | 143 | $3,742 | $26 |
| Rosuvastatin | 28 | $2,084 | $74 |
| Atorvastatin | 159 | $1,933 | $12 |
| Bisoprolol | 18 | $1,698 | $94 |
| Bisoprolol-Hydrochlorothiazide | 21 | $1,506 | $72 |
| Albuterol Sulfate Hfa | 16 | $1,073 | $67 |
| Raloxifene | 12 | $773 | $64 |
| Lisinopril | 68 | $741 | $11 |
| Simvastatin | 66 | $700 | $11 |
| Triamterene-Hydrochlorothiazid | 41 | $592 | $14 |
| Omeprazole | 30 | $566 | $19 |
| Metoprolol | 13 | $525 | $40 |
| Escitalopram | 39 | $508 | $13 |
| Losartan | 41 | $499 | $12 |
| Valsartan-Hydrochlorothiazide | 13 | $495 | $38 |
| Fluticasone Propionate | 17 | $483 | $28 |
| Pravastatin | 14 | $453 | $32 |
| Hydrochlorothiazide | 54 | $291 | $5 |
| Amlodipine Besylate | 29 | $288 | $10 |
| Montelukast | 19 | $260 | $14 |
| Alendronate | 27 | $253 | $9 |
| Nitrofurantoin Mono-Macro | 14 | $230 | $16 |
| Lovastatin | 12 | $187 | $16 |
| Metformin | 18 | $184 | $10 |
| Sertraline | 16 | $176 | $11 |
| Meloxicam | 14 | $169 | $12 |
| Gabapentin | 21 | $166 | $8 |
| Metformin Hcl Er | 26 | $160 | $6 |
| Citalopram Hbr | 14 | $116 | $8 |
2019: 27 drugs
| Breo Ellipta | 12 | $4,410 | $367 |
| Levothyroxine | 159 | $3,604 | $23 |
| Atorvastatin | 160 | $2,681 | $17 |
| Rosuvastatin | 30 | $1,904 | $63 |
| Bisoprolol | 15 | $1,392 | $93 |
| Celecoxib | 21 | $1,251 | $60 |
| Bisoprolol-Hydrochlorothiazide | 23 | $1,097 | $48 |
| Valsartan-Hydrochlorothiazide | 19 | $971 | $51 |
| Simvastatin | 63 | $651 | $10 |
| Lisinopril | 60 | $630 | $11 |
| Losartan | 19 | $599 | $32 |
| Omeprazole | 28 | $559 | $20 |
| Metoprolol | 16 | $532 | $33 |
| Triamterene-Hydrochlorothiazid | 28 | $514 | $18 |
| Montelukast | 13 | $383 | $29 |
| Pravastatin | 11 | $380 | $35 |
| Bupropion Xl | 11 | $328 | $30 |
| Sertraline | 20 | $311 | $16 |
| Alendronate | 34 | $273 | $8 |
| Escitalopram | 34 | $249 | $7 |
| Amlodipine Besylate | 31 | $232 | $7 |
| Gabapentin | 16 | $216 | $13 |
| Metformin Hcl Er | 28 | $191 | $7 |
| Citalopram Hbr | 15 | $160 | $11 |
| Hydrochlorothiazide | 20 | $158 | $8 |
| Metformin | 21 | $149 | $7 |
| Prednisone | 11 | $67 | $6 |
2018: 36 drugs
| Atorvastatin | 196 | $3,717 | $19 |
| Levothyroxine | 153 | $3,560 | $23 |
| Raloxifene | 14 | $2,218 | $158 |
| Bisoprolol | 25 | $1,434 | $57 |
| Ezetimibe | 13 | $1,347 | $104 |
| Valsartan-Hydrochlorothiazide | 29 | $1,061 | $37 |
| Celecoxib | 15 | $1,025 | $68 |
| Escitalopram | 55 | $970 | $18 |
| Synthroid | 17 | $933 | $55 |
| Simvastatin | 74 | $781 | $11 |
| Lisinopril | 77 | $719 | $9 |
| Omeprazole | 37 | $620 | $17 |
| Zolpidem | 51 | $593 | $12 |
| Trospium Chloride | 11 | $587 | $53 |
| Rosuvastatin | 12 | $542 | $45 |
| Pravastatin | 12 | $540 | $45 |
| Bisoprolol-Hydrochlorothiazide | 25 | $524 | $21 |
| Triamterene-Hydrochlorothiazid | 21 | $437 | $21 |
| Pantoprazole | 17 | $416 | $24 |
| Amlodipine Besylate | 49 | $363 | $7 |
| Losartan | 23 | $362 | $16 |
| Alendronate | 37 | $353 | $10 |
| Gabapentin | 27 | $256 | $9 |
| Lorazepam | 31 | $244 | $8 |
| Donepezil | 12 | $195 | $16 |
| Lovastatin | 11 | $190 | $17 |
| Alprazolam | 27 | $178 | $7 |
| Citalopram Hbr | 28 | $174 | $6 |
| Hydrochlorothiazide | 28 | $171 | $6 |
| Carvedilol | 15 | $130 | $9 |
| Hydrocodone-Acetaminophen | 12 | $122 | $10 |
| Spironolactone | 16 | $113 | $7 |
| Metformin | 17 | $108 | $6 |
| Metformin Hcl Er | 12 | $104 | $9 |
| Prednisone | 15 | $91 | $6 |
| Metoprolol | 11 | $90 | $8 |
2017: 35 drugs
| Metformin Hcl Er | 20 | $25,655 | $1,283 |
| Levothyroxine | 129 | $3,344 | $26 |
| Atorvastatin | 128 | $2,356 | $18 |
| Synthroid | 24 | $1,414 | $59 |
| Celecoxib | 20 | $1,342 | $67 |
| Bisoprolol | 36 | $1,135 | $32 |
| Valsartan-Hydrochlorothiazide | 34 | $1,054 | $31 |
| Simvastatin | 94 | $649 | $7 |
| Lisinopril | 69 | $598 | $9 |
| Rosuvastatin | 11 | $595 | $54 |
| Omeprazole | 30 | $574 | $19 |
| Zolpidem | 45 | $532 | $12 |
| Bisoprolol-Hydrochlorothiazide | 41 | $522 | $13 |
| Metoprolol | 11 | $512 | $47 |
| Pravastatin | 12 | $438 | $36 |
| Alendronate | 44 | $404 | $9 |
| Triamterene-Hydrochlorothiazid | 19 | $395 | $21 |
| Escitalopram | 42 | $386 | $9 |
| Pantoprazole | 14 | $362 | $26 |
| Losartan | 13 | $308 | $24 |
| Amlodipine Besylate | 45 | $304 | $7 |
| Fluticasone Propionate | 15 | $292 | $19 |
| Lovastatin | 17 | $282 | $17 |
| Hydrocodone-Acetaminophen | 20 | $278 | $14 |
| Hydrochlorothiazide | 30 | $209 | $7 |
| Isosorbide Mononitrate Er | 11 | $178 | $16 |
| Citalopram Hbr | 19 | $174 | $9 |
| Lorazepam | 22 | $159 | $7 |
| Prednisone | 20 | $152 | $8 |
| Alprazolam | 27 | $128 | $5 |
| Metoprolol | 15 | $125 | $8 |
| Carvedilol | 19 | $110 | $6 |
| Metformin | 18 | $108 | $6 |
| Spironolactone | 15 | $101 | $7 |
| Benazepril | 14 | $72 | $5 |
2016: 39 drugs
| Metformin Hcl Er | 44 | $16,190 | $368 |
| Potassium Chloride | 18 | $4,720 | $262 |
| Levothyroxine | 122 | $2,637 | $22 |
| Bisoprolol | 36 | $2,497 | $69 |
| Atorvastatin | 110 | $2,221 | $20 |
| Synthroid | 25 | $1,449 | $58 |
| Tirosint | 13 | $1,420 | $109 |
| Celecoxib | 13 | $1,143 | $88 |
| Simvastatin | 88 | $877 | $10 |
| Pravastatin | 13 | $774 | $60 |
| Temazepam | 12 | $759 | $63 |
| Bisoprolol-Hydrochlorothiazide | 44 | $658 | $15 |
| Lisinopril | 88 | $657 | $7 |
| Omeprazole | 34 | $588 | $17 |
| Lorazepam | 44 | $576 | $13 |
| Valsartan-Hydrochlorothiazide | 35 | $528 | $15 |
| Lovastatin | 20 | $449 | $22 |
| Metoprolol | 11 | $446 | $41 |
| Amlodipine Besylate | 58 | $434 | $7 |
| Alendronate | 56 | $395 | $7 |
| Hydrocodone-Acetaminophen | 11 | $362 | $33 |
| Triamterene-Hydrochlorothiazid | 21 | $342 | $16 |
| Losartan | 15 | $340 | $23 |
| Escitalopram | 33 | $333 | $10 |
| Pantoprazole | 16 | $300 | $19 |
| Zolpidem | 23 | $272 | $12 |
| Hydrochlorothiazide | 51 | $211 | $4 |
| Fluticasone Propionate | 13 | $210 | $16 |
| Gabapentin | 16 | $157 | $10 |
| Alprazolam | 19 | $157 | $8 |
| Prednisone | 16 | $138 | $9 |
| Metformin | 21 | $137 | $7 |
| Citalopram Hbr | 11 | $126 | $11 |
| Furosemide | 21 | $119 | $6 |
| Metoprolol | 14 | $114 | $8 |
| Isosorbide Mononitrate Er | 12 | $114 | $9 |
| Carvedilol | 17 | $97 | $6 |
| Spironolactone | 13 | $93 | $7 |
| Benazepril | 11 | $47 | $4 |
2015: 34 drugs
| Potassium Chloride | 21 | $3,917 | $187 |
| Crestor | 11 | $3,692 | $336 |
| Levothyroxine | 153 | $3,066 | $20 |
| Celecoxib | 17 | $2,589 | $152 |
| Atorvastatin | 108 | $2,059 | $19 |
| Bisoprolol | 47 | $1,478 | $31 |
| Metformin Hcl Er | 33 | $1,210 | $37 |
| Synthroid | 19 | $1,111 | $58 |
| Simvastatin | 92 | $691 | $8 |
| Metoprolol | 19 | $669 | $35 |
| Lisinopril | 95 | $552 | $6 |
| Zolpidem | 24 | $544 | $23 |
| Valsartan-Hydrochlorothiazide | 29 | $519 | $18 |
| Omeprazole | 40 | $497 | $12 |
| Bisoprolol-Hydrochlorothiazide | 45 | $454 | $10 |
| Fluticasone Propionate | 29 | $409 | $14 |
| Escitalopram | 41 | $392 | $10 |
| Amlodipine Besylate | 76 | $371 | $5 |
| Lovastatin | 24 | $365 | $15 |
| Alendronate | 60 | $333 | $6 |
| Donepezil | 28 | $306 | $11 |
| Methotrexate | 11 | $263 | $24 |
| Pantoprazole | 14 | $259 | $19 |
| Metformin | 32 | $259 | $8 |
| Lorazepam | 18 | $231 | $13 |
| Prednisone | 22 | $224 | $10 |
| Hydrochlorothiazide | 37 | $210 | $6 |
| Levetiracetam | 15 | $190 | $13 |
| Famotidine | 11 | $184 | $17 |
| Metoprolol | 13 | $105 | $8 |
| Alprazolam | 18 | $88 | $5 |
| Carvedilol | 13 | $80 | $6 |
| Spironolactone | 12 | $69 | $6 |
| Furosemide | 17 | $68 | $4 |
2014: 34 drugs
| Crestor | 23 | $5,534 | $241 |
| Actonel | 13 | $4,259 | $328 |
| Advair Diskus | 11 | $4,099 | $373 |
| Atorvastatin | 92 | $2,017 | $22 |
| Qvar | 12 | $1,842 | $153 |
| Levothyroxine | 95 | $1,746 | $18 |
| Synthroid | 21 | $1,112 | $53 |
| Potassium Chloride | 15 | $1,105 | $74 |
| Simvastatin | 109 | $936 | $9 |
| Lisinopril | 83 | $754 | $9 |
| Bisoprolol | 22 | $629 | $29 |
| Amlodipine Besylate | 61 | $543 | $9 |
| Alendronate | 58 | $541 | $9 |
| Lovastatin | 25 | $495 | $20 |
| Metformin | 26 | $304 | $12 |
| Escitalopram | 13 | $296 | $23 |
| Fluticasone Propionate | 13 | $283 | $22 |
| Zolpidem | 24 | $258 | $11 |
| Bisoprolol-Hydrochlorothiazide | 18 | $246 | $14 |
| Prednisone | 16 | $227 | $14 |
| Carvedilol | 18 | $220 | $12 |
| Citalopram Hbr | 23 | $219 | $10 |
| Warfarin | 11 | $219 | $20 |
| Omeprazole | 22 | $197 | $9 |
| Clopidogrel | 12 | $170 | $14 |
| Alprazolam | 17 | $152 | $9 |
| Hydrochlorothiazide | 25 | $149 | $6 |
| Metformin Hcl Er | 16 | $133 | $8 |
| Torsemide | 11 | $131 | $12 |
| Donepezil | 11 | $130 | $12 |
| Triamterene-Hydrochlorothiazid | 11 | $121 | $11 |
| Furosemide | 27 | $105 | $4 |
| Atenolol | 11 | $83 | $8 |
| Lisinopril-Hydrochlorothiazide | 15 | $59 | $4 |
2013: 40 drugs
| Advair Diskus | 12 | $4,415 | $368 |
| Crestor | 14 | $3,215 | $230 |
| Atorvastatin | 101 | $3,043 | $30 |
| Benicar | 13 | $1,897 | $146 |
| Actonel | 12 | $1,866 | $155 |
| Synthroid | 36 | $1,165 | $32 |
| Simvastatin | 103 | $984 | $10 |
| Escitalopram | 25 | $964 | $39 |
| Metoprolol | 28 | $891 | $32 |
| Potassium Chloride | 25 | $836 | $33 |
| Bisoprolol | 25 | $783 | $31 |
| Lovastatin | 36 | $774 | $22 |
| Levothyroxine | 35 | $671 | $19 |
| Nifedipine Er | 14 | $650 | $46 |
| Valsartan-Hydrochlorothiazide | 12 | $647 | $54 |
| Lisinopril | 76 | $627 | $8 |
| Omeprazole | 38 | $550 | $14 |
| Amlodipine Besylate | 35 | $422 | $12 |
| Citalopram Hbr | 46 | $357 | $8 |
| Bisoprolol-Hydrochlorothiazide | 15 | $357 | $24 |
| Methotrexate | 13 | $313 | $24 |
| Levetiracetam | 17 | $295 | $17 |
| Carvedilol | 21 | $271 | $13 |
| Metformin | 14 | $253 | $18 |
| Alendronate | 25 | $236 | $9 |
| Warfarin | 12 | $229 | $19 |
| Olanzapine | 12 | $212 | $18 |
| Hydrochlorothiazide | 22 | $187 | $9 |
| Glyburide | 20 | $183 | $9 |
| Triamterene-Hctz | 13 | $169 | $13 |
| Metformin Hcl Er | 19 | $157 | $8 |
| Losartan | 11 | $146 | $13 |
| Torsemide | 11 | $137 | $12 |
| Lorazepam | 16 | $129 | $8 |
| Metoprolol | 16 | $99 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $92 | $8 |
| Alprazolam | 15 | $81 | $5 |
| Prednisone | 14 | $71 | $5 |
| Amitriptyline | 14 | $69 | $5 |
| Furosemide | 12 | $42 | $3 |
Money from drug and device companies
$383 in 2025
| 2025 | 7 | 28 | None | $383 |
| 2024 | 9 | 12 | None | $229 |
| 2023 | 13 | 33 | None | $679 |
| 2022 | 16 | 23 | None | $481 |
| 2021 | 10 | 29 | None | $409 |
| 2020 | 3 | 4 | None | $82 |
| 2019 | 3 | 5 | None | $104 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $188 | 3 payments
|
| Astellas Pharma US | Veozah | $62 | 3 payments
|
| Lilly USA | Mounjaro | $35 | 2 payments
|
| Novo Nordisk | Rybelsus | $30 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
| Agios Pharmaceuticals | Pyrukynd | $23 | 1 payment
|
See all 12 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-19 | Breztri | $21 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-19 | Jardiance | $23 |
| Astellas Pharma US | Meals · 2025-10-30 | Veozah | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-11 | Breztri | $15 |
| Lilly USA | Meals · 2025-07-28 | Mounjaro | $20 |
| Novo Nordisk | Meals · 2025-05-21 | Rybelsus | $30 |
| Astellas Pharma US | Meals · 2025-03-06 | Veozah | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-04 | Airsupra | $152 |
| Agios Pharmaceuticals | Meals · 2025-03-04 | Pyrukynd | $23 |
| Lilly USA | Meals · 2025-01-27 | Mounjaro | $15 |
| Astellas Pharma US | Meals · 2025-01-21 | Veozah | $21 |
| Kowa Pharmaceuticals America | Meals · 2025-01-09 | Zoryve | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $229
| Novo Nordisk | Ozempic | $68 | 4 payments
|
| Agios Pharmaceuticals | Pyrukynd | $32 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $23 | 1 payment
|
| Abiomed | Impella | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $21 | 1 payment
|
| Lilly USA | Jardiance | $14 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $14 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $13 | 1 payment
|
2023: $679
| Otsuka America Pharmaceutical | Rexulti | $101 | 5 payments
|
| Lilly USA | Mounjaro | $101 | 5 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $70 | 4 payments
|
| Astellas Pharma US | Veozah | $66 | 3 payments
|
| Novo Nordisk | Ozempic | $57 | 3 payments
|
| GlaxoSmithKline | Arexvy | $57 | 2 payments
|
| Pfizer | Comirnaty | $47 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $44 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $41 | 2 payments
|
| Nestle Healthcare Nutrition | Zenpep | $38 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $24 | 1 payment
|
| Lundbeck | Rexulti | $19 | 1 payment
|
| Amgen | Otezla | $15 | 1 payment
|
2022: $481
| Abbvie | Vraylar | $63 | 3 payments
|
| Lilly USA | Mounjaro | $57 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $39 | 2 payments
|
| IBSA Pharma | Tirosint | $36 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $35 | 2 payments
|
| Bausch Health US | Aplenzin | $35 | 2 payments
|
| Pfizer | Prevnar 20 | $28 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $26 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $25 | 1 payment
|
| Abbott Laboratories | Proclaim | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $22 | 1 payment
|
| Avanir Pharmaceuticals | Nuedexta | $22 | 1 payment
|
| Amgen | Repatha | $21 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $19 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $16 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $14 | 1 payment
|
2021: $409
| Janssen Pharmaceuticals | Xarelto | $118 | 14 payments
|
| Pfizer | Cologuard Dna Capture Reagents | $64 | 3 payments
|
| AbbVie | Ubrelvy | $58 | 3 payments
|
| Esperion Therapeutics | Nexletol | $42 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $35 | 2 payments
|
| Amgen | Otezla | $23 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $20 | 1 payment
|
| Lilly USA | Emgality | $18 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $18 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $14 | 1 payment
|
2020: $82
| Amgen | Aimovig | $35 | 2 payments
|
| Allergan | Ubrelvy | $25 | 1 payment
|
| Nabriva Therapeutics plc | Xenleta | $23 | 1 payment
|
2019: $104
| AstraZeneca Pharmaceuticals LP | Farxiga | $44 | 2 payments
|
| Merck Sharp & Dohme | Januvia | $37 | 2 payments
|
| Astellas Pharma US | Myrbetriq | $23 | 1 payment
|
Professional record
- NPI
- 1801816343
- Licence
- CA A87310California A87310: Current · expires 2027-12-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1860 El Camino Real, Suite 321, Burlingame, CA, 94010
- NPI first listed
- 2006-07-20
- NPI last updated
- 2012-08-28
This is when the NPI record was last certified, not a medical board exam.